Emmessar Biotech & Nutrition submits copy of revised financial results

26 Dec 2015

Emmessar Biotech & Nutrition has submitted a copy of the Revised Financial Results for the period ended September 30, 2015 with the necessary corrections duly done in Profit Before Tax in the Segment wise section.

The above information is a part of company’s filings submitted to BSE.




Related Emmessar Biotech & Nutrition Ltd. Links:

Emmessar Biotech&Nut Share Price

11.68 0.00 (0.00%) Jan 16, 18:01
1 Year Price Chart
Company Name CMP
Sun Pharma Inds. 454.45
Lupin 766.25
Dr. Reddys Lab 3033.65
Piramal Enterprises 1627.05
Cadila Healthcare 269.10
View more..
Sensex vs Emmessar Biotech&Nut
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719